| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |